Product Images Clopidogrel
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 12 images provide visual information about the product associated with Clopidogrel NDC 70518-0400 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Clopidogrel 75mg 70518 0400 00
Clopidogrel is a tablet with a strength of 75 mg. The bottle contains 90 tablets and is distributed by RemedyRepack. It is intended for prescription use only and has an NDC number of 70518-0400-00. The product was manufactured by Macleods Pharma in Baddi, India. The lot number and expiration date of this product are not currently available. The product should be stored at 20-25°C (58-77°F), with permissible excursions to 15-30°C (59-86°F), and kept out of the reach of children. For usage instructions, refer to the package insert.*
MM2 - Clopidogrel 75mg 70518 0400 01
Clopidogrel is a medication available in tablet form with a strength of 75mg. The package contains 30 tablets and it is RX only. The tablet is packaged by RemedyRepack Inc. and the original manufacturing company is Macleods Pharma located in Baddi, India. The medication is required to be stored at a temperature of 20-25°C and excursions permitted to 15-30°C. The package insert should be referred to for directions for use. The exact expiry date and lot number are not available. It is important to keep this medication out of reach of children.*
figure-03 - clopidogrel fig 3
figure-1 - clopidogrel figure 01
figure-2 - clopidogrel figure 02
This document appears to be a graph or chart comparing the efficacy of two different drugs, Placebo with Aspirin and Clopidogrel with Aspirin. The chart shows a comparison of the efficacy over a duration of 12 months of follow-up. The efficacy is measured on the Y-axis, and on the X-axis, there are the number of months. The Clopidogrel plus Aspirin appears to have significantly higher efficacy as compared to Placebo plus Aspirin. There is also the mention of the use of other standard therapies.*
figure-4 - clopidogrel figure 04
The text appears to be a statistical summary of data related to two groups of patients who were treated with either a placebo or Clopidogrel, and all receieved aspirin. The data includes the number and percentage of deaths in each group, along with a mention of a 7% proportional risk reduction in the group treated with Clopidogrel. The text also includes a chart or graph with data points labeled "Days since randomization".*
figure-5 - clopidogrel figure 05
clopidogrel figure 07
This is a study or data analysis on the use of aspirin and clopidogrel for a certain condition or disease. The result of the analysis shows a statistical significance with a p-value of 0.045. The study was conducted for several months with a follow-up period, although the exact duration is not specified.*
figure-3 - clopidogrel figure 3
This seems to be the output of a medical report or study, analyzing the effectiveness of a drug known as Clopidogrel compared to a Placebo. There are some numeric values and codes indicating data sets, but there is not enough information to derive any conclusions regarding the study itself.*
figure-6 - clopidogrel figure 6
figure-8 - clopidogrel figure 8
structure - clopidogrel structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.